The Forgotten Frontline: Are Incomplete UC Deployments Causing Avoidable Risk? 
Ineo Expands MoveTrack™ Global Compensation Capabilities With Integrated Global Gross-Up Across 100+ Countries Timescale Valuation Rockets to Over $1B with $110M Round, Marking the Explosive Rise of Time-Series Data
The funding, led by new investor Tiger Global, will fuel Timescale’s thriving business, with 20x…
FHLBank Pittsburgh Announces Full Year and Fourth Quarter 2021 Financial Results
PITTSBURGH–(BUSINESS WIRE)–The Federal Home Loan Bank of Pittsburgh (FHLBank) announced today unaudited financial results for…
VistaVu Acquires ResolvIT to Expand Mid-Market Capabilities
Acquisition signals a significant investment into deepening VistaVu’s industry experience and SAP Business One offerings…
Aware and Anonybit Pave the Way for Privacy-Preserving Identity Management Solutions
Partnership Between the Companies Will Address Biometric Data Security Concerns and Enable Users to Secure…
LIDDS secures financing of up to 40.8 MSEK to create foundation for new partnerships based on the NanoZolid® technology
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the company has entered into a…
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
FORT WORTH, TX , Feb. 22, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or…
Qualigen Therapeutics CEO Michael Poirier Provides Letter to Shareholders
CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified…
Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting…
Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron Sublineage Virus as Well as BA.1 and BA.1+R346k Omicron Viruses
STI-9167 neutralizing antibody (nAb) maintains high neutralization potency against the recently emerging Omicron sublineage BA.2…
Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
Praxis Precision Medicines to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
QuantuMDx announces approval of its Rapid Q-POC™ SARS-CoV-2 assay in the UK under CTDA legislation
QuantuMDx announces approval of its Rapid Q-POCTMSARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE…
Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s…
Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss
Data Published in Cancer Research, a journal of the American Association for Cancer Research Publication…
Albireo to Report Q4 and Year-End 2021 Financial Results on March 1
— Conference call and webcast to be held at 10:00 a.m. ET — BOSTON, Feb….
Chinook Therapeutics Announces Upcoming Presentations at 4th Annual Chronic Kidney Disease Drug Development Summit
SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022
MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Black Diamond Therapeutics Appoints Elizabeth Montgomery as Chief People Officer
CAMBRIDGE, Mass. and NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 1, 2022
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Athenex Announces Appointment of Chief Financial Officer
BUFFALO, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…